Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?

Shroff R, Quinlan C, Mitsnefes M.

Pediatr Nephrol. 2011 Jun;26(6):853-65. doi: 10.1007/s00467-010-1691-y. Epub 2010 Nov 16. Review.

PMID:
21080003
2.

Dysregulated mineral metabolism in children with chronic kidney disease.

Shroff R.

Curr Opin Nephrol Hypertens. 2011 May;20(3):233-40. doi: 10.1097/MNH.0b013e3283455e8c. Review.

PMID:
21422924
3.
4.

[Experimental study of the mechanism for vascular calcification in chronic kidney disease].

Persy V.

Verh K Acad Geneeskd Belg. 2008;70(4):285-303. Review. Dutch.

PMID:
19166100
5.

Mechanistic insights into vascular calcification in CKD.

Shroff R, Long DA, Shanahan C.

J Am Soc Nephrol. 2013 Feb;24(2):179-89. doi: 10.1681/ASN.2011121191. Epub 2012 Nov 8. Review.

6.

Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5.

García-Canton C, Bosch E, Ramírez A, Gonzalez Y, Auyanet I, Guerra R, Perez MA, Fernández E, Toledo A, Lago M, Checa MD.

Nephrol Dial Transplant. 2011 Jul;26(7):2250-6. doi: 10.1093/ndt/gfq650. Epub 2010 Oct 18.

PMID:
20956810
7.

Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.

Qunibi WY, Nolan CA, Ayus JC.

Kidney Int Suppl. 2002 Dec;(82):S73-80. Review.

8.

Cardiovascular calcification in nondialyzed patients with chronic kidney disease.

Qunibi WY.

Semin Dial. 2007 Mar-Apr;20(2):134-8. Review.

PMID:
17374087
10.

Monitoring cardiovascular risk factors in children on dialysis.

Shroff R.

Perit Dial Int. 2009 Feb;29 Suppl 2:S173-5. Review.

PMID:
19270210
11.

Mineral metabolism disturbances in patients with chronic kidney disease.

Kestenbaum B, Belozeroff V.

Eur J Clin Invest. 2007 Aug;37(8):607-22. Review.

PMID:
17635571
12.

Vascular calcification in chronic kidney disease.

Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ.

Clin Sci (Lond). 2010 Apr 28;119(3):111-21. doi: 10.1042/CS20090631. Review.

PMID:
20443781
13.

Novel insights into vascular calcification.

Ketteler M, Giachelli C.

Kidney Int Suppl. 2006 Dec;(105):S5-9. Review.

PMID:
17136112
14.

Vitamin D and vascular calcification in chronic kidney disease.

Mizobuchi M, Ogata H, Koiwa F, Kinugasa E, Akizawa T.

Bone. 2009 Jul;45 Suppl 1:S26-9. doi: 10.1016/j.bone.2009.01.011. Epub 2009 Jan 23. Review.

PMID:
19442619
15.

Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM.

J Am Soc Nephrol. 2010 Jan;21(1):103-12. doi: 10.1681/ASN.2009060640. Epub 2009 Dec 3.

16.

Challenges in the therapy of secondary hyperparathyroidism.

Wood C, González EA, Martin KJ.

Ther Apher Dial. 2005 Feb;9(1):4-8.

PMID:
15828898
17.

Cardiovascular disease and its relationship with chronic kidney disease.

Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, Zhang PY.

Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2918-26. Review.

18.

Consequences of chronic kidney disease--mineral and bone disorder: a progressive disease.

Smith KR, Smelt SC.

Nephrol Nurs J. 2009 Jan-Feb;36(1):49-55.

PMID:
19271624
19.

Osteogenic regulation of vascular calcification: an early perspective.

Vattikuti R, Towler DA.

Am J Physiol Endocrinol Metab. 2004 May;286(5):E686-96. Review.

20.

Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease.

Patidar A, Singh DK, Winocour P, Farrington K, Baydoun AR.

Clin Sci (Lond). 2013 Sep;125(5):237-45. doi: 10.1042/CS20120638.

PMID:
23464884

Supplemental Content

Support Center